Medtronic PLC is trading 7.4% up at $79.20 after reporting strong fiscal 2026 results and an earnings beat.
- The company achieved its best annual revenue growth in a decade, driven by higher-than-expected Q4 revenue and EPS.
- Investors are reacting positively to strong performance in the Cardiovascular and Cardiac Ablation Solutions segments, looking past a relatively cautious FY27 profit outlook.